EKF Diagnostics Holdings plc (OTCMKTS:EKDHF – Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 30,078 shares, a growth of ∞ from the July 30th total of 0 shares. Based on an average daily volume of 19,800 shares, the short-interest ratio is presently 1.5 days.
EKF Diagnostics Price Performance
EKF Diagnostics stock remained flat at $0.34 during midday trading on Friday. EKF Diagnostics has a 12-month low of $0.29 and a 12-month high of $0.42. The stock has a 50 day moving average of $0.34 and a 200-day moving average of $0.34.
About EKF Diagnostics
EKF Diagnostics Holdings plc (OTCMKTS: EKDHF) is a global in vitro diagnostics company that develops, manufactures and markets a broad range of point-of-care and laboratory analyzers, reagents and consumables. The company’s product portfolio addresses key segments of the diagnostic testing market, including haematology, biochemistry, immunoassay, haemostasis and diabetes monitoring.
EKF Diagnostics offers peripheral blood analyzers designed for use in clinical laboratories, hospitals and veterinary clinics, along with handheld and benchtop devices for rapid on-site testing.
See Also
- Five stocks we like better than EKF Diagnostics
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
